The survival impact of significant delays between surgery and radiochemotherapy in glioblastoma patients: A retrospective analysis from a large tertiary center

•The time interval does not seem to be a clear prognostic factor.•Moderate delays might be associated with an optimal survival.•Prospective clinical trials of treatment timing are highly warranted.